Prasad R. Kudalkar, M.D.
Seeking cures for cancer and an improved quality of life are Dr. Kudalkar’s primary goals. “I strive to be a good listener and provide compassionate, state-of-the-art cancer care.”
Dr. Kudalkar is board certified in internal medicine, medical oncology, hematology, and hospice and palliative medicine. His specialty is medical oncology/hematology. And brain tumors are an area of interest. After graduating from medical school at Seth G. S. Medical College in India, he completed his internship and residency at Millard Fillmore Hospital in Buffalo. He followed this with a fellowship in hematology and oncology at North Shore University Hospital/New York University School of Medicine in Manhasset, NY.
Dr. Kudalkar enjoys swimming, canoeing, kayaking, biking, and travel.
Swimming, canoeing, kayaking, biking, and travel.
Seth G. S. Medical College. Bombay, India
Millard Fillmore Hospital, Buffalo, NY
Millard Fillmore Hospital, Buffalo, NY
North Shore University Hospital/New York University School of Medicine, Manhasset, NY
CERTIFICATIONS & LICENSURES
American Board of Internal Medicine, Internal Medicine
American Board of Internal Medicine, Medical Oncology
American Board of Internal Medicine, Hematology
American Board of Internal Medicine, Hospice and Palliative Medicine
American Academy of Hospice and Palliative Care Medicine
American Medical Association
American Society of Clinical Oncology
American Society of Hematology
Cancer Committee, Westchester Hospital
Cancer Committee, Clinton Memorial Hospital
Kudalkar P.R., Lichtman S.M.: Geriatric Hematology: The Role of the Hematologist in Geriatric Care. Blood 2002; 100(Suppl. 1a): 99a
Kudalkar P.R., Brody J., Buccholtz M.S.: Zinc Induced Copper Deficiency Anemia and Leucopenia: A Case Report. Blood 2002; 100(Suppl. 1a): 99a
Albesiano, E., Messmer, B.T., Damle, R.N., Allen, S.L., Kudalkar, P.R., Kolitz, J.E., Vinciguerra, V.P., Rai, K.R., Chiorazzi, N.: Activation-induced cytidine deaminase expression in B-CLL. Blood 2002; 100(Suppl. 1a): 99a
Messmer, D., Messmer, B.T., Cesar, D., Albesiano, E., Telusma, G., Damle, R., Allen, S.L., Kudalkar, P., Kolitz, J.E., Loscalzo, J., Ho, C., Rai, K.R., Hellerstein, M., Chiorazzi, N.: Direction measurement of B-CLL cell production and turnover in vivo. Blood 2002; 100(Suppl. 1a): 169a
Messmer B.T., Messmer D., Allen S.A., Kudalkar P.R., Rai K.R., Chiorazzi N.: Three Subsets of Chronic Lymphocytic Leukemia Defined by Gene Expression Profiles. Blood 2002; 100(Suppl. 1a): 378a
A. K. Yenamandra, J. E. Kolitz, P. R. Kudalkar, J. Joshi, J. Brody, S. Ludlum, P. Koduru; A novel cytogenetic abnormality in biphenotypic acute leukemia (BAL) involving BCL11A and Immunoglobulin heavy chain (IgH) region. Proceedings of American Society of Clinical Oncology 22: 2003 (abstract 245)
P. R. Kudalkar, I. Dibo, T. Bradley, A. Rizzo. Cancer screening in primary care: A single institution experience. Proceedings of American Society of Clinical Oncology 22: 2003 (abstract 2185)
Rajendra N. Damle, Julia Tai, Martin Lesser, Prasad R. Kudalkar, Tarun Wasil, Bradley T. Messmer, Steven L. Allen, Kanti R. Rai, Nicholas Chiorazzi: In-Depth Analysis of Telomere Length Reveals Intraclonal Heterogeneity of Circulating B-CLL Cells
Rajendra N. Damle, Franak M. Batliwalla, Fabio Ghiotto, Angelo Valetto, Emilia Albesiano, Cristina Sison, Steven L. Allen, Jonathan Kolitz, Vincent P. Vinciguerra, Prasad Kudalkar, Tarun Wasil, Kanti R. Rai, Manlio Ferrarini, Peter K. Gregersen, and Nicholas Chiorazzi. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.. Blood. 2004 Jan 15;103:375-82
Bradley T. Messmer, Davorka Messmer, Steven L. Allen, Jonathan E. Kolitz, Prasad Kudalkar, Denise Cesar, Elizabeth J. Murphy, Prasad Koduru, Manlio Ferrarini, Simona Zupo, Giovanna Cutrona, Rajendra N. Damle, Tarun Wasil, Kanti R. Rai, Marc K. Hellerstein and Nicholas Chiorazzi. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J. Clin. Invest. 2005 March 1;115:755-764
As a member of our OHC physician team, Dr. Kudalkar has full access to the OHC Clinical Trial research program.
We encourage our patients to discuss all of their healthcare options — including Clinical Trial research programs — with their doctor.
The following are recent reviews provided by actual OHC patients:
"Dr. Kudalkar and the staff in the West Chester and Hamilton offices have gone above and beyond in making my treatment over the last 2+ years as easy as possible."
"Dr. Kudalkar is a compassionate and understanding doctor who has made my diagnosis, treatment, and continued follow-up care an easier process for me."
"Dr. Prasad Kudalkar is very kind to me and always talks to me about my cancer and the treatment that might be needed in the future. I hope to continue seeing Dr. Kudalkar for all of my oncology needs."